| Filed On | Filing |
|---|---|
| 16 Oct 2026 |
8-K: Other Events
On October 16, 2026, the board of directors (the “Board”) of NRx Pharmaceuticals, Inc. (the “Company”) established December 17, 2026 as the date of the 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”) and set October 28, 2... |
| 05 Oct 2026 |
8-K: Entry into a Material Definitive Agreement
NRx Defense Systems, an NRx Company (Nasdaq:NRXP) Awarded $11 Million Dollar DARPA Prime Contract to Evaluate Robotic Magnetic Stimulation in conjunction with NRX-101 for Treatment of Resistant Depression |
| 16 Sep 2026 |
8-K: Other Events
NRx Pharmaceuticals (Nasdaq: NRXP) Reports Update from the FDA Revising Previous Major Amendment to a Minor Amendment for Preservative-free Ketamine |
| 14 Sep 2026 |
8-K: Regulation FD Disclosure
On September 8, 2026, representatives of NRx Pharmaceuticals, Inc. (the “Company”) used the investor presentation furnished as Exhibit 99.1 to this Current Report on Form 8-K in connection with presentations and meetings with investors a... |
| 17 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 14 Aug 2026 | FORM 10-Q |
| 07 Aug 2026 | 8-K: Regulation FD Disclosure |
| 22 Jul 2026 | 8-K: Other Events |
| 04 Jun 2026 | 8-K: Entry into a Material Definitive Agreement; Other Events |
| 03 Jun 2026 | FORM 424B5 |
| 02 Jun 2026 | FORM 424B5 |
| 02 Jun 2026 | 8-K: Other Events |
| 22 May 2026 | 25-NSE |
| 15 May 2026 | SCHEDULE 13G/A |
| 15 May 2026 | FORM 10-Q |
| 24 Mar 2026 | 8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders |
| 23 Mar 2026 | FORM 10-K |
| 24 Feb 2026 | FORM DEFA14A |
| 23 Feb 2026 | ARS |
| 23 Feb 2026 |
Proxy statement: annual meeting on March 23, 2026
say-on-pay vote |
Loading...
